{
  "type": "hyp",
  "text": "We demonstrate that cross-linking CD30 with an anti-CD30L engagement sequence activates a transcription factor called CD30-responsive element (CD30L) in the human immunodeficiency virus type 1 (HIV-1) enhancer.\n",
  "self": {
    "NER": {
      "answers": [
        "CD30",
        "1",
        "HIV-1"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the transcription factor that is activated by cross-linking?",
          "What type of virus is activated by cross-linking CD30 with an anti-CD",
          "What is the enhancer of CD30?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "We",
        "that cross-linking CD30",
        "an anti-CD30L engagement sequence",
        "a transcription factor",
        "CD30L",
        "the human immunodeficiency virus",
        "type 1 (HIV-1) enhancer"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What did the authors demonstrate?",
          "What does the cytokine cytokine do?",
          "What does cross-linking CD30 with activate a transcription factor?",
          "What does CD30-responsive element activate?",
          "What is the transcription factor that is activated by cross-linking CD30 with an anti",
          "What type of virus is activated by CD30-responsive element?",
          "What is the transcription factor called?"
        ]
      }
    }
  },
  "asked": {
    "What is the ligand that causes HIV expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "CD30",
        "answerability": 0.7061781883239746,
        "ground_truth": {
          "CD30": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What did the authors demonstrate about cross-linking CD30 with an anti-CD30-": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.679584264755249,
        "ground_truth": {
          "We": {
            "bertscore": 0.6054112315177917,
            "f1": 0
          }
        }
      }
    },
    "What does the study demonstrate?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.46474844217300415,
        "ground_truth": {
          "that cross-linking CD30": {
            "bertscore": 0.6664813160896301,
            "f1": 0
          }
        }
      }
    },
    "What does the study demonstrate can result in HIV expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "cross-linking CD30 with an anti-CD30L engagement sequence",
        "answerability": 0.6047720909118652,
        "ground_truth": {
          "an anti-CD30-specific monoclonal antibody": {
            "bertscore": 0.7782858610153198,
            "f1": 0
          }
        }
      }
    },
    "What does the anti-CD30-specific antibody mimic?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005805075168609619,
        "ground_truth": {
          "the described biological activities": {
            "bertscore": 0.6289010643959045,
            "f1": 0
          }
        }
      }
    },
    "What is the ligand that mimics the biological activities of CD30?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.02339911460876465,
        "ground_truth": {
          "CD30L": {
            "bertscore": 0.6516712307929993,
            "f1": 0
          }
        }
      }
    },
    "What does cross-linking CD30 with an anti-CD30-specific monoclon": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.1800602674484253,
        "ground_truth": {
          "HIV expression": {
            "bertscore": 0.7030201554298401,
            "f1": 0
          }
        }
      }
    }
  }
}